Q: What is Taltz used for?

Taltz is used to treat: ankylosing spondylitis non-radiographic axial spondyloarthritis plaque psoriasis and others

Q: How does Taltz work?

How Taltz Functions Taltz is a biologic medication known as an interleukin-17A (IL-17A) antagonist. It is a monoclonal antibody, which is a type of protein designed to recognize and bind to a specific target in the body. In certain autoimmune conditions, the immune system becomes overactive and produces high levels of a protein called IL-17A. This protein acts as a messenger that signals the body to create inflammation. In the skin, this leads to the rapid buildup of cells that form plaques. In the joints, it causes swelling, pain, and potential damage. Taltz works by identifying and attaching itself to the IL-17A protein. Once bound, the protein can no longer interact with its receptors on the surface of cells. By blocking this interaction, Taltz interrupts the inflammatory cycle. This helps to: Reduce the redness, thickening, and scaling of the skin. Decrease joint pain and swelling. Lower the overall level of inflammation in the body. Because this medication specifically targets one part of the immune system rather than suppressing the entire system, it is considered a targeted therapy. However, because it affects immune activity, it may impact the body's ability to respond to some infections.

Q: What are the active ingredients in Taltz?

The active ingredient in Taltz is ixekizumab .

Q: What are the side effects of Taltz?

Common side effects of Taltz may include: Upper respiratory infection Injection site reactions Nausea Always consult with a healthcare professional about potential side effects.

Q: What drug class is Taltz?

Taltz belongs to the IL-17A antagonist drug class.

Q: What is the dosage of Taltz and how do I take it?

How to Use Taltz Taltz is given as a subcutaneous injection (under the skin). It is available as a single-dose prefilled syringe or an autoinjector. Your healthcare provider will show you how to prepare and inject the medication before you attempt to do it yourself. Injection Sites Common areas for injection include the front of the thighs, the abdomen, or the back of the upper arms. It is important to rotate the injection site each time you use the medication. Avoid injecting into skin that is sore, bruised, red, hard, or affected by psoriasis plaques. Preparation and Administration Remove the medication from the refrigerator and let it reach room temperature for about 30 minutes before injecting. Do not shake the syringe or autoinjector. Check the liquid to ensure it is clear and colorless to slightly yellow. Do not use if the liquid is cloudy, discolored, or contains large particles. Each device is for one-time use only and should be disposed of in a puncture-resistant sharps container. Missed Doses If you miss a dose of Taltz, use it as soon as you remember. Afterward, continue with your next dose at the regularly scheduled time. Do not use extra medicine to make up for a missed dose.

Q: Is Taltz safe during pregnancy and breastfeeding?

Pregnancy There are no adequate and well-controlled studies of Taltz in pregnant women. While animal reproduction studies did not show evidence of harm to the fetus, the results of animal studies do not always predict human response. Because of this, Taltz should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. If you are pregnant or plan to become pregnant, inform your healthcare provider. They can help you weigh the risks of the medication against the risks of leaving your condition untreated. There may also be pregnancy registries available to monitor the health of mothers and babies exposed to the medication. Breastfeeding It is not known whether ixekizumab, the active ingredient in Taltz, is excreted in human milk or if it has any effect on the breastfed infant or milk production. Because many drugs are present in human milk and the potential for adverse effects is unknown, caution is advised. The decision to continue or discontinue breastfeeding while using Taltz should be made in consultation with a medical professional, considering the developmental and health benefits of breastfeeding alongside the mother's clinical need for the drug.

Q: What is the FDA approval status of Taltz?

FDA Approval History The U.S. Food and Drug Administration (FDA) first approved Taltz in March 2016. It was initially indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Approved Indications Since its initial release, the FDA has expanded the approved uses for Taltz to include: Plaque Psoriasis: Treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 6 years and older. Psoriatic Arthritis: Treatment of adults with active psoriatic arthritis. Ankylosing Spondylitis: Treatment of adults with active ankylosing spondylitis. Non-radiographic Axial Spondyloarthritis: Treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation. Regulatory Status and Safety Taltz is classified as an interleukin-17A (IL-17A) antagonist. It is available only by prescription and is administered via subcutaneous injection. There are currently no FDA Boxed Warnings associated with this medication. However, regulatory labeling requires healthcare providers to screen patients for tuberculosis (TB) before starting treatment, as the drug may increase the risk of infections.

Question 1

What is Taltz?

Accepted Answer

Taltz is a biological medication classified as a monoclonal antibody. It works by specifically binding to interleukin-17A, which is a naturally occurring protein involved in the body's inflammatory and immune responses.

By neutralizing this protein, the medication helps to interfere with the inflammatory process. This action assists in reducing the underlying inflammation that contributes to the progression of certain health conditions.

Question 2

What is Taltz used for?

Accepted Answer

Taltz is used to treat:

ankylosing spondylitis
non-radiographic axial spondyloarthritis
plaque psoriasis
and others

Question 3

How does Taltz work?

Accepted Answer

How Taltz Functions

Taltz is a biologic medication known as an interleukin-17A (IL-17A) antagonist. It is a monoclonal antibody, which is a type of protein designed to recognize and bind to a specific target in the body.

In certain autoimmune conditions, the immune system becomes overactive and produces high levels of a protein called IL-17A. This protein acts as a messenger that signals the body to create inflammation. In the skin, this leads to the rapid buildup of cells that form plaques. In the joints, it causes swelling, pain, and potential damage.

Taltz works by identifying and attaching itself to the IL-17A protein. Once bound, the protein can no longer interact with its receptors on the surface of cells. By blocking this interaction, Taltz interrupts the inflammatory cycle. This helps to:

Reduce the redness, thickening, and scaling of the skin.
Decrease joint pain and swelling.
Lower the overall level of inflammation in the body.

Because this medication specifically targets one part of the immune system rather than suppressing the entire system, it is considered a targeted therapy. However, because it affects immune activity, it may impact the body's ability to respond to some infections.

Question 4

What are the active ingredients in Taltz?

Accepted Answer

The active ingredient in Taltz is ixekizumab.

Question 5

What are the side effects of Taltz?

Accepted Answer

Common side effects of Taltz may include:

Upper respiratory infection
Injection site reactions
Nausea

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Taltz?

Accepted Answer

Taltz belongs to the IL-17A antagonist drug class.

Question 7

What is the dosage of Taltz and how do I take it?

Accepted Answer

How to Use Taltz

Taltz is given as a subcutaneous injection (under the skin). It is available as a single-dose prefilled syringe or an autoinjector. Your healthcare provider will show you how to prepare and inject the medication before you attempt to do it yourself.

Injection Sites

Common areas for injection include the front of the thighs, the abdomen, or the back of the upper arms. It is important to rotate the injection site each time you use the medication. Avoid injecting into skin that is sore, bruised, red, hard, or affected by psoriasis plaques.

Preparation and Administration

Remove the medication from the refrigerator and let it reach room temperature for about 30 minutes before injecting.
Do not shake the syringe or autoinjector.
Check the liquid to ensure it is clear and colorless to slightly yellow. Do not use if the liquid is cloudy, discolored, or contains large particles.
Each device is for one-time use only and should be disposed of in a puncture-resistant sharps container.

Missed Doses

If you miss a dose of Taltz, use it as soon as you remember. Afterward, continue with your next dose at the regularly scheduled time. Do not use extra medicine to make up for a missed dose.

Question 8

Is Taltz safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies of Taltz in pregnant women. While animal reproduction studies did not show evidence of harm to the fetus, the results of animal studies do not always predict human response. Because of this, Taltz should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

If you are pregnant or plan to become pregnant, inform your healthcare provider. They can help you weigh the risks of the medication against the risks of leaving your condition untreated. There may also be pregnancy registries available to monitor the health of mothers and babies exposed to the medication.

Breastfeeding

It is not known whether ixekizumab, the active ingredient in Taltz, is excreted in human milk or if it has any effect on the breastfed infant or milk production. Because many drugs are present in human milk and the potential for adverse effects is unknown, caution is advised.

The decision to continue or discontinue breastfeeding while using Taltz should be made in consultation with a medical professional, considering the developmental and health benefits of breastfeeding alongside the mother's clinical need for the drug.

Question 9

What forms and strengths does Taltz come in?

Accepted Answer

Taltz is supplied as a clear and colorless to slightly yellow solution for injection under the skin. It is available in two types of single-dose delivery systems:

Autoinjector: A pre-filled, single-use device designed for easy administration.
Prefilled Syringe: A single-use syringe containing a pre-measured dose of the medication.

Both delivery methods are designed for subcutaneous use and are intended to be disposed of after a single use.

Question 10

What is the FDA approval status of Taltz?

Accepted Answer

FDA Approval History

The U.S. Food and Drug Administration (FDA) first approved Taltz in March 2016. It was initially indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Approved Indications

Since its initial release, the FDA has expanded the approved uses for Taltz to include:

Plaque Psoriasis: Treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 6 years and older.
Psoriatic Arthritis: Treatment of adults with active psoriatic arthritis.
Ankylosing Spondylitis: Treatment of adults with active ankylosing spondylitis.
Non-radiographic Axial Spondyloarthritis: Treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.

Regulatory Status and Safety

Taltz is classified as an interleukin-17A (IL-17A) antagonist. It is available only by prescription and is administered via subcutaneous injection. There are currently no FDA Boxed Warnings associated with this medication. However, regulatory labeling requires healthcare providers to screen patients for tuberculosis (TB) before starting treatment, as the drug may increase the risk of infections.

Question 11

What should I know about Taltz and cost?

Accepted Answer

Factors Influencing Cost

The out-of-pocket cost for Taltz can vary based on several factors, including your specific health insurance plan, your pharmacy, and your prescribed dosage schedule. Because it is a biologic medication, it is often classified as a specialty drug, which may affect how it is covered under your plan's formulary.

Insurance and Prior Authorization

Most insurance providers require prior authorization for Taltz. This process involves your healthcare provider submitting documentation to your insurance company to prove the medical necessity of the drug before coverage is approved. Patients may be responsible for a co-payment or co-insurance amount once the drug is approved.

Financial Assistance Options

There are several programs designed to help reduce the cost of Taltz for eligible patients:

Manufacturer Savings Cards: Patients with commercial insurance may qualify for a savings card that reduces monthly co-pays to a lower fixed amount.
Patient Assistance Programs: For individuals who are uninsured or underinsured, there are programs that may provide the medication at no cost or a significantly reduced rate based on financial need.
Specialty Pharmacies: Taltz is typically dispensed through specialty pharmacies rather than standard retail pharmacies. These pharmacies often have staff dedicated to helping patients navigate insurance claims and find financial assistance.

Taltz

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Taltz

Hospitals.net Disclosure